ArticleTranslational lung cancer research2026
A radiomics nomogram integrated with radiological features for preoperative prediction of lung nodule invasiveness: comparison with Lung-RADS.
Article in Translational lung cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preoperative identification of early-stage lung adenocarcinoma, particularly minimal lesions, holds critical implications for clinical decision-making. However, accurate diagnosis of pulmonary nodules' malignancy remains challenging when relying solely on conventional clinical parameters or radiological features, due to the lack of specificity in certain instances of early lesions. This study aims to develop a nodule-level composite model using radiomics methods and compare its performance with the Lung CT Screening Reporting and Data System (Lung-RADS) in predicting the invasiveness using preoperative low-dose computed tomography (LDCT) scan with 1 mm slice thickness. Methods: From June 2019 to October 2023, the patients who were pathologically diagnosed with the initial primary lung nodules were enrolled in the retrospective cohort. To predict invasiveness of nodule, nodule-level models, including radiomics, radiological, and combined models, were developed to categorize the nodules into the invasiveness and non-invasiveness groups. Radiomics features were extracted from the tumor region to develop a radiomics model after a three-stage feature reduction procedure, resulting in a Radscore for each nodule. The nodules were randomly divided into two groups, with a ratio of 7:3. The area under the receiver operating characteristic curve (AUC), accuracy, and other relevant measures were employed to assess the models' performance and discriminative ability. A nomogram that combines optimal radiomics and clinical-radiological features was compared to Lung-RADS using various evaluation methods, including calibration curve analysis, decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results: A total of 393 patients were enrolled, including 67 with multiple nodules. Altogether, 487 nodules were analysed, comprising 374 in the invasiveness and 113 in the non-invasiveness group. The radiological model identified two risk factors: nodule type and a vessel convergence sign. The nomogram achieved a training-set AUC of 0.91, surpassing the Lung-RADS system (AUC: 0.669) in nodule assessment. Notably, significant improvements in NRI and IDI, as well as higher net benefits, were shown by the DCA. Conclusions: The nomogram based on radiomics and radiological features offers supplementary information for preoperative prediction of the invasiveness of lung nodules, surpassing both the commonly used Lung-RADS and single models in guiding diagnosis and treatment strategies for lung nodules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.